Few Pediatric Cancer Drugs Reach Phase 3 or Approval Will Pass May 15, 2026

https://www.medscape.com/viewarticle/few-pediatric-cancer-drugs-reach-phase-3-or-approval-2026a1000fsh Most anticancer drugs that enter clinical testing in children and adolescents fail to reach late-phase trials or earn pediatric regulatory approval, according to the authors of new research.